Turner Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-41,300
Closed -$552K 233
2016
Q4
$552K Sell
41,300
-17,590
-30% -$284K 0.22% 141
2016
Q3
$1.09M Sell
58,890
-16,390
-22% -$289K 0.36% 95
2016
Q2
$922K Buy
+75,280
New +$567K 0.29% 102
2015
Q1
Sell
-34,800
Closed -$955K 452
2014
Q4
$955K Sell
34,800
-176,690
-84% -$4.3M 0.11% 277
2014
Q3
$4.1M Buy
+211,490
New +$3.88M 0.25% 127

Other funds holding EXAS

Turner Investments's EXAS Position: Q1 2017 in Review

Turner Investments sold out of Exact Sciences (EXAS) in Q1 2017, closing a stake of 41,300 shares — an estimated $552K sold.

Turner Investments first reported a position in EXAS in Q3 2014 and held it in 5 quarters. The position peaked at $4.1M in Q3 2014. 225 funds tracked by Wall St. Rank hold EXAS as of Q1 2017.

  • Turner Investments reported no remaining Exact Sciences position as of Q1 2017 after selling out during the quarter.
  • Turner Investments sold 41,300 Exact Sciences shares in Q1 2017, an estimated $552K.
  • Turner Investments first reported a position in Exact Sciences in Q3 2014 and held it in 5 quarters.
  • Turner Investments's Exact Sciences position peaked at $4.1M in Q3 2014.
  • 225 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.